By increasing the level of PLB, that is, phosphorylated at Thr-17, and decreasing the expression level of total PLB, WXKL may improve the frequency-dependent acceleration of relaxation in cardiac myocytes, thereby improving cardiac function and preventing arrhythmia. This evidence concerns the gene PLN and Arrhythmia.